Navigation Links
Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making
Date:8/14/2009

Los Angeles, London, New Delhi, Singapore and Washington DC (July 27, 2009) According to a study in a special issue of Medical Decision Making, a large-scale, covert anthrax attack on a large city would overwhelm hospital resources even with an extremely effective public health response, primarily because of expected delays in detecting the attack and initiating a response to it.

The article "Predicting Hospital Surge after a Large-Scale Anthrax Attack: A Model-Based Analysis of CDC's Cities Readiness Initiative Prophylaxis Recommendations," examines one of the CDC's principal bioterrorism-response programs, the Cities Readiness Initiative (CRI), a program that recommends the medical countermeasures necessary to minimize the hospital surge resulting from anthrax-related illness and response in the first two days after a major bioterrorism attack.

The researchers found that a CRI-compliant prophylaxis campaign starting two days after exposure would protect as many as 86% of exposed individuals from illness. However, each additional day needed to complete the campaign would result in as much as 3% more hospitalizations in the exposed population. Unsustainable levels of hospitalizations would result from delays in detecting and initiating response to large-scale, covert aerosol anthrax releases in a major city, even with highly effective mass prophylaxis campaigns.

The article, written by Nathaniel Hupert, incorporates some of the latest type of modeling techniques scientists use in the disaster preparedness.field. Such models have become increasingly important to public health officials and hospital administrators. To improve the consistency and quality of these models, the Society for Medical Decision Making convened experts to recommend best practices for modeling the public health response to a terror attack. Their article, also published in the current issue of Medical Decision Making, is entitled

    <
    '/>"/>


Contact: Jim Gilden
media.inquiries@sagepub.com
SAGE Publications
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology technology :

1. Thomson Reuters Examines Highly Cited Research in Bioterrorism
2. JMAR Technologies Raises Awareness of BioSentry -- A High Tech Counter to Bioterrorism
3. Avalanche photodiodes target bioterrorism agents
4. Avalanche photodiodes target bioterrorism agents
5. BioNeutral Announces a BREAKTHROUGH in the Fight Against Bioterrorism
6. New study examines effects of Graniteville, S.C., chlorine gas disaster
7. Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas
8. Millstone Medical Outsourcing Relocates Memphis Distribution Center Within 72 Hours of Tornado Disaster
9. Triage study challenges notions of emergency medical response to disaster
10. ORNL resilience plan to help Tennessee, Mississippi and South Carolina communities beat disaster
11. BIO Visitors Bring Viral Preparedness to Atlanta
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Colo. and THOUSAND OAKS, Calif., Dec. 14 /PRNewswire-FirstCall/ ... and Amgen Inc.(Nasdaq: AMGN ) today announced ... exclusive worldwide rights to Array,s small-molecule glucokinase activator ... Phase 1 clinical trial in patients with Type ... of the agreement, Array will receive an upfront ...
(Date:12/14/2009)... The third edition of ... published by the Infusion Nurses Society (INS), ... extravasation.(1) Anthracyclines are a group of chemotherapy ... have been used in the treatment of various ... ,, According to the INS publication: "In ...
(Date:12/14/2009)... Decision Resources, one of the world,s ... healthcare issues, finds that, owing to the launches ... market will increase more than sevenfold from $790 ... in the United States, France, Germany, Italy, Spain, ... Pharmacor report entitled Atrial Fibrillation finds ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) ... announced public offering have exercised in full their ... common stock at the public offering price of ... option increases the size of the offering to ... Dendreon expects to receive net proceeds from ...
Breaking Biology Technology:Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3
... issue, Wisconsin Technology Network launches a special section devoted ... is not new, it is only now beginning to ... that perspective that we present this series of articles ... by Wisconsin experts in business and academia. , ,In ...
... -- Third Wave Technologies Inc. has filed suit ... two products, the company announced on Tuesday. The suits were ... Friday filed suit against Digene Corp., seeking a ... papilloma virus (HPV) products. , ,On Tuesday, Third Wave filed ...
... parents' generation of corporate leaders. , ,A quarter-century ago, ... lips of gray-haired, gray-suited corporate executives. Today, cool is ... yet have it. , ,At the Olympia Resort on ... arts groups met to brainstorm strategies for making Wisconsin ...
Other Biology Technology:RFID starting to make real impact on business 2RFID starting to make real impact on business 3Third Wave files patent suits against Digene, Chiron and Bayer 2Tech leaders call for more creativity 2
(Date:12/16/2009)... BIO-key International, Inc. (OTC Bulletin ... safety and finger-based biometric identification solutions, announced ... a Special Shareholder Meeting held today approved ... Division to Interact911 Mobile Systems Inc. Of ... favor and 1.2% were opposed. ,, (Logo: ...
(Date:12/16/2009)... WALL, N.J., Dec. 9 BIO-key ... leader in finger-based biometric identification solutions, today ... world,s most respected security publications, named BIO-key ... in the Access Control sub-category Biometrics. ,, ... to Peter Stephenson, technology editor, SC Magazine, ...
(Date:12/15/2009)... The 2009 Frost & Sullivan ... presented to Sagem Securite (Safran Group) for ... award recognises the company,s expertise in advanced ... offering novel, value-added products to end users. ... ,, "Sagem Securite has been involved in ...
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4IPC The Hospitalist Company Acquires Two New England Practices 61664 1IPC The Hospitalist Company Acquires Two New England Practices 61664 2Mylans President of Europe Middle East and Africa Elected President of European Generic Medicines Association 6393 1Mylans President of Europe Middle East and Africa Elected President of European Generic Medicines Association 6393 2MS Need Not Preclude Pregnancy 61660 1MS Need Not Preclude Pregnancy 61660 2
... University of Pennsylvania School of Medicine have discovered that ... used to study HIV in macaque monkeys provides the ... an unmodified vaccine. This multi-year study found that the ... effects of a vaccine derived from the DNA of ...
... portions of the human genome with those of other ... unidentified human genes, and found extensions of several hundred ... idea that as organisms evolve, sections of genetic code ... different ways., The research is reported by Adam Siepel, ...
... PITTSBURGH Carnegie Mellon University graduate engineering students Shahzeen Attari, ... Samaras are first-place winners in a letter-writing competition called ... ... by Johnson Controls Inc., asked students to demonstrate their ...
Other Biology News:Penn researchers find monkeys able to fend off AIDS-like symptoms with enhanced HIV vaccine 2Evolutionary comparison finds new human genes 2Evolutionary comparison finds new human genes 3Carnegie Mellon students win contest 2Carnegie Mellon students win contest 3
... unique human proteins on a 1x3 ... a cross section of all cellular ... high-quality results. Additional control proteins and ... validity and reproducibility., ,UNIchip protein microarrays ...
... UNIchip AV-400 contains 400 unique ... nitrocellulose-coated glass slide. The proteins, all ... Ontology classification, are arrayed in quadruplicate ... and a specific chip layout guarantee ...
...
... E.Coli glycerol stocks contained in standard 96-well ... clones with approximately 5,000 clones per plate. ... plate well, the corresponding subplate is screened ... the positive well(s). Cells from a positive ...
Biology Products: